Interpace Biosciences, Inc. financial data

Symbol
IDXG on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
Waterview Plaza, Suite 310, 2001 Route 46, Parsippany, NJ
State of incorporation
DE
Fiscal year end
December 31
Former names
Interpace Diagnostics Group, Inc. (to 11/1/2019), PDI INC (to 12/22/2015), PROFESSIONAL DETAILING INC (to 11/13/2002)
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 90.1 % -22.8%
Quick Ratio 10.2 % -10.9%
Debt-to-equity -46.4 % +0.52%
Return On Equity -16.8 % -386%
Return On Assets 49.7 % +278%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.42M shares +1.07%
Common Stock, Shares, Outstanding 4.41M shares +1.33%
Entity Public Float 4M USD +5.65%
Common Stock, Value, Issued 406K USD +0.25%
Weighted Average Number of Shares Outstanding, Basic 4.39M shares +1.62%
Weighted Average Number of Shares Outstanding, Diluted 15.7M shares +261%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 46.9M USD +17.2%
Cost of Revenue 17M USD +13.5%
Research and Development Expense 676K USD +6.29%
Selling and Marketing Expense 11.7M USD +13.9%
General and Administrative Expense 9.49M USD +1.31%
Operating Income (Loss) 8.11M USD +105%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6.95M USD +205%
Income Tax Expense (Benefit) 4K USD -76.5%
Net Income (Loss) Attributable to Parent 6.7M USD +243%
Earnings Per Share, Basic 1.42 USD/shares +216%
Earnings Per Share, Diluted 0.4 USD/shares -11.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.46M USD -58.2%
Accounts Receivable, after Allowance for Credit Loss, Current 8.54M USD +68.3%
Inventory, Net 1.21M USD -1.3%
Other Assets, Current 1.77M USD -3.97%
Assets, Current 11.8M USD +13%
Property, Plant and Equipment, Net 1.36M USD +72.3%
Operating Lease, Right-of-Use Asset 1.61M USD -13.5%
Other Assets, Noncurrent 45K USD 0%
Assets 14.8M USD +12.8%
Accounts Payable, Current 1.66M USD +7.45%
Employee-related Liabilities, Current 2.21M USD +12.1%
Liabilities, Current 10.6M USD -7.18%
Long-term Debt and Lease Obligation 1.75M USD -41.1%
Operating Lease, Liability, Noncurrent 1.18M USD -19.6%
Other Liabilities, Noncurrent 5.21M USD +4.89%
Liabilities 17M USD -23.1%
Retained Earnings (Accumulated Deficit) -235M USD +2.77%
Stockholders' Equity Attributable to Parent -2.22M USD +96%
Liabilities and Equity 14.8M USD +12.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -58K USD -105%
Net Cash Provided by (Used in) Financing Activities -600K USD -100%
Net Cash Provided by (Used in) Investing Activities -28K USD +56.9%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 4.54M shares +2.07%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -686K USD -189%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.46M USD -58.2%
Deferred Tax Assets, Valuation Allowance 35.1M USD -4.99%
Operating Lease, Liability 1.57M USD -15.3%
Payments to Acquire Property, Plant, and Equipment 28K USD -56.9%
Lessee, Operating Lease, Liability, to be Paid 1.93M USD -19.8%
Property, Plant and Equipment, Gross 4.21M USD +26.2%
Operating Lease, Liability, Current 383K USD +1.59%
Lessee, Operating Lease, Liability, to be Paid, Year Two 550K USD +22.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 550K USD -4.35%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 359K USD -34.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 550K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 24.1M USD -3.43%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 877K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 275K USD
Amortization of Intangible Assets 900K USD -30.8%
Depreciation, Depletion and Amortization 356K USD -54.4%
Deferred Tax Assets, Net of Valuation Allowance 168K USD +700%
Share-based Payment Arrangement, Expense 291K USD -53.8%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%